Superior effectiveness of tofacitinib compared to vedolizumab in anti-TNF experienced ulcerative colitis patients: a nationwide Dutch Registry study

Autor: Tessa Straatmijer, Vince B.C. Biemans, Marijn Visschedijk, Frank Hoentjen, Annemarie de Vries, Adriaan A. van Bodegraven, Alexander Bodelier, Nanne K.H. de Boer, Gerard Dijkstra, Noortje Festen, Carmen Horjus, Jeroen M. Jansen, Bindia Jharap, Wout Mares, Fiona D.M. van Schaik, Cyriel Ponsioen, Tessa Romkens, Nidhi Srivastava, Michael M.P. J.A. van der Voorn, Rachel West, Janneke van der Woude, Marije D.J. Wolvers, Marieke Pierik, Andrea E. van der Meulen-de Jong, Marjolijn Duijvestein, Malena Schlotter, Martine van Workum, Dirk de Jong, Willemijn van Dop, S. van der Marel, Hayat El Ghabzouri, Kamila Talhaoui, Bas Oldenburg, Nynke Boontje, Herma Fidder, Meike Hirdes, Rob H. Creemers, J. Hoekstra, Jael Smid, Zlatan Mujagic, Marthe François-Verweij, Toos Schakel- van den Berge, Jeroen Maljaars, Rosaline Theeuwen, Denise van den Berg, Suzanne Gerretsen, Xenia Yocarini, Geert D’Haens, Mark Lowenberg, Joep Grootjans, Krisztina Gecse, Gerd Bouma, Petra Waaijenberg, Bart Muskens

Publikováno v: Clinical Gastroenterology and Hepatology, 21(1), 182-191.e2. ELSEVIER SCIENCE INC
Clinical Gastroenterology and Hepatology, 21, 1, pp. 182-191.e2
Clinical Gastroenterology and Hepatology, 21(1), 182-191.e2. W.B. Saunders Ltd
Clinical Gastroenterology and Hepatology, 21, 182-191.e2
Clinical gastroenterology and hepatology. Elsevier Science
Clinical gastroenterology and hepatology, 21(1), 182-191.e2. W.B. Saunders Ltd
Initiative on Crohn and Colitis 2023, ' Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients : A Nationwide Dutch Registry Study ', Clinical Gastroenterology and Hepatology, vol. 21, no. 1, pp. 182-191.e2 . https://doi.org/10.1016/j.cgh.2022.04.038
Clinical Gastroenterology and Hepatology, 21(1), 182-191.e2. W.B. Saunders

Background & Aims: Clinicians face difficulty in when and in what order to position biologics and Janus kinase inhibitors in patients with anti-tumor necrosis factor-alpha (TNF) refractory ulcerative colitis (UC). We aimed to compare the effectivenes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16c5fd40e67e975df5ce34fd01d6aa67
https://research.rug.nl/en/publications/4d7e144b-6332-47f9-9cee-542a2092238d